Indications |
Oral Depression Adult: 10 mg once daily, increased if necessary. Max: 20 mg daily. Elderly: Half the adult dose. Hepatic impairment: Dosage adjustments may be required. Oral Obsessive compulsive disorder Adult: 10 mg once daily, increased if necessary. Max: 20 mg daily. Elderly: Half the adult dose. Hepatic impairment: Dosage adjustments may be required. Oral Anxiety Adult: 10 mg once daily, increased if necessary. Max: 20 mg daily. Elderly: Half the adult dose. Hepatic impairment: Dosage adjustments may be required. Oral Panic disorder Adult: Initially, 5 mg daily, increased to 10 mg daily after 7 days. Max: 20 mg daily. Elderly: Half the adult dose. Hepatic impairment: Dosage adjustments may be required. Special Populations: Patients with hepatic impairment: 5 mg daily. May increase to 10 mg daily after 2 wk. |
Contraindications |
Concomitant use with or within 2 wk of MAOI withdrawal. |
Warnings / Precautions |
History of mania or seizure disorders; work requiring mental alertness; renal and hepatic impairment; pregnancy, lactation; withdraw gradually. Children and adolescents <18 yr |
Adverse Reactions |
Nausea, diarrhoea, increased sweating, insomnia, impotence, ejaculation disorder, fatigue, somnolence; postural hypotension, sinusitis, taste disturbances. Increased appetite and wt gain. |
Overdose Reactions |
Symptoms include convulsions, coma, dizziness, hypotension, insomnia, nausea, vomiting, sinus tachycardia, somnolence, ECG changes (including QT prolongation and rarely, torsade de pointes). Treatment includes establishing and maintaining an airway to ensure adequate ventilation and oxygenation. Gastric lavage and activated charcoal may be used. Monitor cardiac and vital signs, along with general symptomatic and supportive care. Forced diuresis, dialysis, haemoperfusion, and exchange transfusion may not be useful. |
Drug Interactions |
Increased risk of bleeding when used with aspirin, NSAIDs or drugs that affect coagulation. Serum levels may be reduced by CYP2C19 inducers (e.g. carbamazepine, rifampin, phenytoin) or CYP3A4 inducers (e.g. nafcillin, nevirapine). Serum levels may also be increased by CYP2C19 inhibitors (e.g. fluconazole, fluvoxamine, omeprazole) or CYP3A4 inhibitors (e.g. azole antifungals, clarithromycin). May increase serum levels of desipramine or metoprolol. Increased risk of serotonin syndrome when used with linezolid or sibutramine. Escitalopram may enhance the sedative effects of alcohol. Potentially Fatal: Concomitant administration with MAOIs may lead to serious or fatal reactions; should not be started until at least 2 wk after stopping escitalopram or vice versa. Moclobemide may increase the risk of serotonin syndrome. See Below for More escitalopram Drug Interactions |
Food Interactions |
Increased CNS depression with valerian, St John's wort, kava kava and gotu kola. |
Mechanism of Actions |
Escitalopram selectively inhibits CNS neuronal re-uptake of serotonin (5-HT) and potentiates serotonergic activity. It has minimal effects on norepinephrine and dopamine neuronal re-uptake. Onset: 1-2 wk. Absorption: Readily absorbed from the GI tract (oral). Distribution: Protein-binding: 56%. Metabolism: Hepatic; converted to metabolites. Excretion: Urine (as unchanged drug); 27-32 hr (elimination half-life). |
Administration |
May be taken with or without food. |
Storage Conditions |
Oral: Store at 25°C. |
ATC Classification |
N06AB10 - escitalopram ; Belongs to the class of selective serotonin reuptake inhibitors. Used in the management of depression. |
Storage |
Oral: Store at 25°C. |
Available As |
|
Escitalopram
Post Review about Escitalopram Click here to cancel reply.
Escitalopram Containing Brands
Escitalopram is used in following diseases
Drug - Drug Interactions of Escitalopram
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.